169 related articles for article (PubMed ID: 5123478)
1. [Cytostatic therapy of malignant lymphoma].
Kühböck J
Wien Klin Wochenschr; 1971 Jul; 83(27):516-22. PubMed ID: 5123478
[No Abstract] [Full Text] [Related]
2. [Use of cytostatic drugs in therapy and research].
Wie H
Tidsskr Nor Laegeforen; 1973 Mar; 93(7):443-9. PubMed ID: 4699142
[No Abstract] [Full Text] [Related]
3. [Long-term survivals in lymphomas and generalized lymphosarcomas treated by chemo- and hormonal therapy].
Dubois-Ferrière H
Schweiz Med Wochenschr; 1967 Nov; 97(44):1478-9. PubMed ID: 5631771
[No Abstract] [Full Text] [Related]
4. Combination chemotherapy of Hodgkin's disease.
McElwain TJ
Br J Haematol; 1971 Sep; 21(3):362. PubMed ID: 5569541
[No Abstract] [Full Text] [Related]
5. [Polychemotherapy of Hodgkin's disease].
Delage JM; Blouin R; Barry A
Union Med Can; 1970 Jun; 99(6):1062-7. PubMed ID: 5511498
[No Abstract] [Full Text] [Related]
6. Hodgkin's disease and some solid tumours.
Jelliffe AM
Proc R Soc Med; 1966 Dec; 59(12):1261-8. PubMed ID: 5955849
[No Abstract] [Full Text] [Related]
7. [Effect of a new cytostatic agent (peptichemio) on malignant neoplasms].
Pittermann E; Stacher A; Griendl W
Wien Med Wochenschr; 1974 Apr; 124(14):216. PubMed ID: 4522966
[No Abstract] [Full Text] [Related]
8. [On the effect of a cytostatic of the methylhydrazine group on malignant hemoblastomas].
Böhnel J; Stacher A
Wien Med Wochenschr; 1966 May; 116(21):468-71. PubMed ID: 4863533
[No Abstract] [Full Text] [Related]
9. [Treatment of malignant lymphoma with Peptichemio. Preliminary communication].
Uszyński L; Maj S; Pawelski S
Acta Haematol Pol; 1974; 5(2):153-7. PubMed ID: 4599294
[No Abstract] [Full Text] [Related]
10. [Mechanism of action of antineoplastic agents].
Korolkovas A
Rev Farm Bioquim Univ Sao Paulo; 1971; 9(1):1-60. PubMed ID: 4948630
[No Abstract] [Full Text] [Related]
11. [Treatment of malignant lymphoma].
Maurice PA
Schweiz Med Wochenschr; 1971 Oct; 101(42):1516-9. PubMed ID: 5143016
[No Abstract] [Full Text] [Related]
12. Cytotoxic agents in the treatment of malignant disease.
Br Med J; 1968 Nov; 4(5628):438-9. PubMed ID: 4972069
[No Abstract] [Full Text] [Related]
13. The indication for chemotherapy in the lymphomas.
Rosenberg SA
Proc Natl Cancer Conf; 1970; 6():83-9. PubMed ID: 5458149
[No Abstract] [Full Text] [Related]
14. [Antitumor polychemotherapy].
Alberto P
Poumon Coeur; 1968; 24(1):21-6. PubMed ID: 5652203
[No Abstract] [Full Text] [Related]
15. [Malignant lymphoma].
Streuli RA
Schweiz Rundsch Med Prax; 1981 May; 70(20):909-15. PubMed ID: 7015304
[No Abstract] [Full Text] [Related]
16. [Chemotherapy of malignant systemic diseases with a methylhydrazine derivative, Natulan].
Nissen I; Poulsen EH
Ugeskr Laeger; 1967 Nov; 129(44):1472-6. PubMed ID: 4875225
[No Abstract] [Full Text] [Related]
17. New chemotherapeutic agents in Hodgkin's disease.
Hall TC
Cancer Res; 1966 Jun; 26(6):1297-302. PubMed ID: 5947354
[No Abstract] [Full Text] [Related]
18. [Rational schemes of chemotherapy in different pulmonary forms of lymphogranulomatosis].
Gershanovich ML; Semenov II
Med Radiol (Mosk); 1973 May; 18(5):54-5. PubMed ID: 4769911
[No Abstract] [Full Text] [Related]
19. [Results of radiologic and cytostatic combination therapy in malignant diseases].
Hammer B
Wien Med Wochenschr; 1967 Jun; 117(25):637-41. PubMed ID: 5585442
[No Abstract] [Full Text] [Related]
20. [Hodgkin's disease and hematosarcomas. Treatment trial by 2 methylhydrazines].
Mathe G; Schneider M; Amiel JL; Schwarzenberg L; Cattan A; Schlumberger JR
Concours Med; 1965 Jul; 87(27):4555-62. PubMed ID: 5841618
[No Abstract] [Full Text] [Related]
[Next] [New Search]
